Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Sabbagh

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|July 23, 2020
Alzheimer's disease drug development pipeline: 2020Jeffrey Cummings, Garam Lee, Aaron Ritter, et al.
Journal of Alzheimer'S Disease : JAD|August 24, 2012
KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patientsMarwan Sabbagh, Michael Malek-Ahmadi, Ian Levenson, et al.
Neurology and Therapy|December 28, 2020
Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative ReviewBarry S Baumel, P Murali Doraiswamy, Marwan Sabbagh, et al.
Expert Opinion on Investigational Drugs|May 3, 2017
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015Dev Mehta, Robert Jackson, Gaurav Paul, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 24, 2019
Alzheimer's disease drug development pipeline: 2019Jeffrey Cummings, Garam Lee, Aaron Ritter, et al.
Future Neurology|November 4, 2009
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseasesLih-Fen Lue, Douglas Gordon Walker, Sandra Jacobson, et al.
Alzheimer'S Research & Therapy|August 14, 2020
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approvalMartin Tolar, Susan Abushakra, John A Hey, et al.
Neurobiology of Aging|January 10, 2013
Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytesElaine Delvaux, Karen Bentley, Victoria Stubbs, et al.
Neuroscience Letters|February 16, 2010
Amyloid load in nondemented brains correlates with APOE e4Richard J Caselli, Douglas Walker, Lucia Sue, et al.
Neurobiology of Aging|April 17, 2010
Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's diseaseJens Stieler, Randy Grimes, Don Weber, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia (New York, N. Y.)|July 23, 2020
Alzheimer's disease drug development pipeline: 2020Jeffrey Cummings, Garam Lee, Aaron Ritter, et al.
Journal of Alzheimer'S Disease : JAD|August 24, 2012
KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patientsMarwan Sabbagh, Michael Malek-Ahmadi, Ian Levenson, et al.
Neurology and Therapy|December 28, 2020
Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative ReviewBarry S Baumel, P Murali Doraiswamy, Marwan Sabbagh, et al.
Expert Opinion on Investigational Drugs|May 3, 2017
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015Dev Mehta, Robert Jackson, Gaurav Paul, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 24, 2019
Alzheimer's disease drug development pipeline: 2019Jeffrey Cummings, Garam Lee, Aaron Ritter, et al.
Future Neurology|November 4, 2009
Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseasesLih-Fen Lue, Douglas Gordon Walker, Sandra Jacobson, et al.
Alzheimer'S Research & Therapy|August 14, 2020
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approvalMartin Tolar, Susan Abushakra, John A Hey, et al.
Neurobiology of Aging|January 10, 2013
Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytesElaine Delvaux, Karen Bentley, Victoria Stubbs, et al.
Neuroscience Letters|February 16, 2010
Amyloid load in nondemented brains correlates with APOE e4Richard J Caselli, Douglas Walker, Lucia Sue, et al.
Neurobiology of Aging|April 17, 2010
Multivariate analysis of differential lymphocyte cell cycle activity in Alzheimer's diseaseJens Stieler, Randy Grimes, Don Weber, et al.
Pageof 10